Pradaxa is an anticoagulant drug introduced in October of 2010 as a preventative of blood clots in patients with atrial fibrillation without the regular blood tests required for Coumadin and Warfarin. It quickly became one of the most widely-prescribed blood thinners in the world.
Unfortunately, experts have now linked the drug to serious health risks such as Pradaxa internal bleeding and heart attacks. Although Pradaxa is still on the market, a federal judge recently ruled that those affected can proceed with lawsuits.
News of potential problems with Pradaxa came soon after it was launched. Within six months of its release, the FDA received over 500 reports of Pradaxa internal bleeding injury or death among patients, more than 98% of other drugs.
On December 7, 2011, the FDA announced that it would review the safety of Pradaxa after receiving reports of 3,781 Pradaxa side effects and 542 deaths among users, the most for any drug in 2011. These included internal bleeding in the brain, intestines and kidneys, as well as heart attacks.
In September of 2012, The Journal for The American Medical Association also warned that the FDA may have rushed approval of Pradaxa, overlooking key side effects like Pradaxa bleeding.
If you or a loved one suffered internal bleeding after taking Pradaxa, it is important to speak with a lawyer about your legal options. You could be entitled to substantial compensation for your loss. Contact us today.
While all blood thinner medications have a risk of causing internal bleeding, others can be effectively treated with reversal agents such as PCC, plasma and vitamin K.
In March of 2012, the Journal of Neurosurgery detailed a specific case of a patient who died from uncontrollable bleeding after taking Pradaxa, as well as concerns of doctors that, once Pradaxa causes internal bleeding, there is very little they can do to stop it.
The University of Pécs in Hungary also published a study of Pradaxa in September of 2012, suggesting the risks of the drug outweighed its benefits. Researchers found that patients taking Pradaxa after an acute heart condition were 3 times as likely to suffer an internal bleeding episode.
Lawyers are currently helping those affected by Pradaxa internal bleeding file lawsuits against the manufacturer, Boehringer Ingelheim. Due to the number of claims expected, they have been consolidated into a special federal court in Illinois. Judge David Herndon recently denied attempts by the drug maker to have these cases dismissed.
A lawyer can let you know what compensation is available and how long you have to take action. However, make sure you choose a lawyer qualified for this type of lawsuit who has experience fighting large drug companies. The Drug Resource Center only recommends law firms that specialize in Pradaxa lawsuits.
For more information on the side effects, warnings and legal action related to the drug Pradaxa, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.
Authored by Chris Schroeder